Genesys Capital is a Canadian life sciences venture firm that backs early company creation through its University Seed Fund at pre-seed and seed. Their core thesis is that hospitals and universities are a rich source of new life science companies, and that bringing them in as partners helps research turn into investable businesses. What makes Genesys unique is its LP base of hospital and university partners, including Sunnybrook, UHN, the University of Toronto and McMaster, which gives the fund direct access to deal flow from research institutions.